Stocks / NASDAQ / Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

Our Opinion

Neurocrine Biosciences, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Website: 

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

“The candidate will be directly involved in animal model selection and assay development for the in vivo examination of novel drug targets and screening of potential therapeutic compounds along with study design, execution of procedures and data analysis in a team setting.” Read the following article

Company Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale on January, 1992 and is headquartered in San Diego, CA. [Source: MarketWatch]

Company Website: